FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for prevention of diabetes. Pentaamino acid derivatives of fullerene C60, containing as amino acid residues the remains of the main natural amino acids: glycine, alanine, serine, arginine, valine, threonine, leucine, cysteine, lysine, isoleucine, asparagine, glutamine, methionine, phenylalanine, aspartic and glutamic acids, as well as proline, tyrosine and dihydroxytyrosine.
EFFECT: method reduces the likelihood of developing type 2 diabetes.
1 cl, 4 dwg, 8 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HEPATOPROTECTIVE AND ANTIOXIDANT DRUG FOR ANIMALS BASED ON AQUEOUS SOLUTION OF FULLERENE C, RESVERATROL AND BETAINE HYDROCHLORIDE | 2020 |
|
RU2770534C1 |
| DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
| METHOD OF INDUCING TARGETED DIFFERENTIATION OF MULTIPOTENT PROGENITOR CELLS OF PANCREAS IN INSULIN-PRODUCING BETA CELLS DURING DIABETES | 2014 |
|
RU2579997C2 |
| TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
| ANTIOXIDANT DRUG FOR ANIMALS BASED ON AQUEOUS SOLUTION OF FULLERENE C, RESVERATROL AND ALPHA-LIPOIC ACID | 2022 |
|
RU2807600C1 |
| PREPARATION BASED ON AN AQUEOUS SOLUTION OF FULLERENE C, ZINC, VITAMIN D, C AND QUERCETIN FOR ANIMALS | 2022 |
|
RU2793128C1 |
| HYDRATED N-FULLERENE-AMINO ACID DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458046C1 |
| COMPOSITION FOR STIMULATION OF CELLS' GROWTH AND REGENERATION (VERSIONS) AND METHOD OF COMPOSITION'S MANUFACTURE (VERSIONS) | 2008 |
|
RU2391990C1 |
| AGENT HAVING HYPOGLYCEMIC AND ANTI-INFLAMMATORY ACTIVITY | 2012 |
|
RU2506091C1 |
